Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of BITS7201A in Healthy Volunteers and Participants With Mild Atopic Asthma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, pharmacokinetics, and immunogenicity of BITS7201A in healthy volunteers and participants with mild atopic asthma has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• BITS7201A

Snippet

Sponsor: Genentech, Inc. | Conditions: Mild Atopic Asthma | Phase 1 | Status: COMPLETED